Cargando…

Approved mRNA Vaccines for SARS-CoV-2

Detalles Bibliográficos
Autor principal:	Faiman, Beth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Harborside Press LLC 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844189/ https://www.ncbi.nlm.nih.gov/pubmed/33552658 http://dx.doi.org/10.6004/jadpro.2021.12.1.1

Ejemplares similares

Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine
por: Milane, Lara, et al.
Publicado: (2021)

Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)
por: Parums, Dinah V.
Publicado: (2021)

Hypereosinophilia after vaccination with the SARS-CoV-2 mRNA vaccines
por: Westreich, Aaron, et al.
Publicado: (2023)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
por: Bettini, Emily, et al.
Publicado: (2021)

Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
por: Ali, Kashif, et al.
Publicado: (2021)

Symptomology following mRNA vaccination against SARS-CoV-2
por: Ebinger, Joseph E., et al.
Publicado: (2021)

Immediate reactions after mRNA SARS-CoV-2 vaccination
por: Jeimy, Samira, et al.
Publicado: (2021)

Preclinical data from SARS-CoV-2 mRNA vaccine
por: Vabret, Nicolas
Publicado: (2020)

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
por: Jackson, Lisa A., et al.
Publicado: (2020)

mRNA Vaccines: Possible Tools to Combat SARS-CoV-2
por: Yi, Changhua, et al.
Publicado: (2020)

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
por: Baden, Lindsey R., et al.
Publicado: (2020)

mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2
por: Jin, Yingqi, et al.
Publicado: (2022)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
por: Echaide, Miriam, et al.
Publicado: (2023)

The Safety and Effectiveness of mRNA Vaccines Against SARS-CoV-2
por: Jamous, Yahya F, et al.
Publicado: (2023)

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
por: Zeng, Guangting
Publicado: (2022)

SARS-CoV-2 mRNA vaccination and subsequent herpes zoster: Possible immune reconstitution by mRNA vaccination
por: Ota, Mitsuhito
Publicado: (2022)

New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
por: Arismendez, Alan A., et al.
Publicado: (2023)

Nonirritant concentrations for skin testing with SARS-CoV-2 mRNA vaccine
por: Marcelino, João, et al.
Publicado: (2021)

Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva
por: Ketas, Thomas J., et al.
Publicado: (2021)

Antibody response to mRNA SARS-CoV-2 vaccines in haemodialysis patients
por: Paal, Michael, et al.
Publicado: (2021)

Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva
por: Ketas, Thomas J., et al.
Publicado: (2021)

Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients
por: Romano, Emanuela, et al.
Publicado: (2021)

Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis
por: Rubbert-Roth, Andrea, et al.
Publicado: (2021)

Acute Myocarditis Following mRNA-1273 SARS-CoV-2 Vaccination
por: Williams, Curtis B., et al.
Publicado: (2021)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
por: Wang, Fuzhou, et al.
Publicado: (2020)

Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
por: Widge, Alicia T., et al.
Publicado: (2020)

Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination
por: Patrizio, Armando, et al.
Publicado: (2022)

Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine
por: Grunenwald, Solange, et al.
Publicado: (2022)

SARS-CoV-2 mRNA-based vaccines in the Aicardi Goutières Syndrome
por: Takanohashi, Asako, et al.
Publicado: (2022)

SARS-CoV-2 mRNA vaccination, prostate cancer and steroids: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Development of Bivalent mRNA Vaccines against SARS-CoV-2 Variants
por: Li, Jianglong, et al.
Publicado: (2022)

mRNA Vaccine Mitigates SARS-CoV-2 Infections and COVID-19
por: Kackos, Christina M., et al.
Publicado: (2023)

Persistent myopericarditis after heterologous SARS-CoV-2 mRNA vaccination
por: Wu, Kai Yi, et al.
Publicado: (2023)

Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve?
por: Yildiz, Elif, et al.
Publicado: (2023)

A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®
por: Speich, Benjamin, et al.
Publicado: (2021)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jk25latksshqo01avrj84e76pl